1. Home
  2. TRMK vs ADPT Comparison

TRMK vs ADPT Comparison

Compare TRMK & ADPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Trustmark Corporation

TRMK

Trustmark Corporation

HOLD

Current Price

$40.63

Market Cap

2.3B

Sector

Finance

ML Signal

HOLD

Logo Adaptive Biotechnologies Corporation

ADPT

Adaptive Biotechnologies Corporation

HOLD

Current Price

$15.43

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TRMK
ADPT
Founded
1889
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
2.6B
IPO Year
1987
2019

Fundamental Metrics

Financial Performance
Metric
TRMK
ADPT
Price
$40.63
$15.43
Analyst Decision
Buy
Strong Buy
Analyst Count
3
10
Target Price
$42.67
$16.60
AVG Volume (30 Days)
276.0K
3.0M
Earning Date
01-27-2026
11-05-2025
Dividend Yield
2.36%
N/A
EPS Growth
10.82
N/A
EPS
3.66
N/A
Revenue
$773,338,000.00
$252,754,000.00
Revenue This Year
$58.57
$50.81
Revenue Next Year
$4.65
$1.17
P/E Ratio
$11.10
N/A
Revenue Growth
55.58
42.57
52 Week Low
$29.77
$5.81
52 Week High
$41.34
$20.76

Technical Indicators

Market Signals
Indicator
TRMK
ADPT
Relative Strength Index (RSI) 62.20 44.33
Support Level $37.37 $14.58
Resistance Level $41.22 $16.26
Average True Range (ATR) 1.13 1.13
MACD 0.22 -0.36
Stochastic Oscillator 85.65 13.75

Price Performance

Historical Comparison
TRMK
ADPT

About TRMK Trustmark Corporation

Trustmark Corp is a bank holding company. Through its subsidiaries, the company operates as a financial services organization providing banking and other financial solutions in Alabama, Florida, Mississippi, Tennessee, and Texas. Its principal products and services include Commercial Banking, Consumer Banking, Mortgage Banking, Insurance, Wealth Management and Trust Services, and others. The company is managed along two operating segments: General Banking and Wealth Management. The General Banking segment, which generates the majority of the revenue, provides all traditional banking products and services, including loan deposits, and also consists of internal operations.

About ADPT Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).

Share on Social Networks: